癌症中的表观遗传和线观遗传调节以及治疗前景
Selcen Celik-Uzuner1, Ihsan Nalkiran2, Ugur Uzuner1,3
1Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon, Türkiye.
Frontiers in pharmacology
|March 16, 2026
概括
表观遗传和线观遗传修饰调节了癌细胞的适应性. 用新型药物准这些机制为个性化,代谢知情的癌症疗法提供了有希望的途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 表观遗传修饰 (DNA甲基化,基因组修饰,非编码RNA) 调节癌症中的基因表达.
- 线粒体遗传学涉及线粒体DNA甲基化和蛋白质调节,影响癌症的进展.
- 表观遗传药物 (epi-药物) 对新的癌症疗法至关重要.
研究的目的:
- 审查癌症表观遗传和线观遗传调节的分子机制.
- 为了探索治疗发展和转化相关性的epi-药物.
- 突出结合核和线粒体表观遗传向的需要.
主要方法:
- 叙事审查整合当前证据.
- 分析核和线粒体DNA中的分子机制.
- 检查当前和新兴的表观遗传药物点.
主要成果:
- 表观遗传调节会影响瘤抑制基因,瘤基因和染色质.
- 线粒体遗传学影响氧化酸化,氧化还原平衡和亡.
- 较新的瘤药物针对EZH2,IDH1/2,DOT1L,扩大精确瘤学.
- 线粒体表观遗传调制解决了代谢重编程和抵抗.
结论:
- 针对核和线粒体表观遗传网络对于有效的癌症治疗至关重要.
- 需要基于生物标志物,组合和有机细胞向的方法.
- 通过全面的表观遗传向,可以开发个性化,代谢知情的癌症干预措施.
相关概念视频
Epigenetic Regulation
4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.1K
Epigenetic Regulation
34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Epigenetic Regulation
26.2K
26.2K
Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K


